DNA X, Inc. (SONM) stock: key figures, P/E, revenue and dividend
Information Technology · United States · ISIN US83548F4081
DNA X, Inc. financials
| Fiscal year | 2025 |
|---|---|
| Operating income | -5.41 m USD |
| EBIT | -20.86 m USD |
| Net income | -20.66 m USD |
| Diluted EPS – continuing operations | -28.58 USD |
Full history since 2000, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About DNA X, Inc.
DNA X, Inc. provides cryptocurrency trading services worldwide. The company operates a cryptocurrency trading platform that allows users to trade and swap cryptocurrencies for other cryptocurrencies or cash-equivalent currencies. It markets its services through word of mouth and earned media on social media platforms. The company serves individual cryptocurrency traders. The company was formerly known as Sonim Technologies, Inc. and changed its name to DNA X, Inc. in January 2026. DNA X, Inc. was incorporated in 1999 and is headquartered in San Diego, California.
More stocks
- VITASPRING BIOMEDICAL CO. LTD. (VSBC)
- NOCERA, INC. (NCRA)
- Vemanti Group, Inc. (VMNT)
- CHASE PACKAGING CORP (WHLT)
- Fly-E Group, Inc. (FLYE)
- PharmaCyte Biotech, Inc. (PMCB)
- Abpro Holdings, Inc. (ABPO)
- Alaunos Therapeutics, Inc. (TCRT)
- MAGELLAN COPPER & GOLD Corp (MAGE)
- Global Warming Solutions, Inc. (GWSO)
- Apimeds Pharmaceuticals US, Inc. (APUS)
- GRI Bio, Inc. (GRI)
Not investment advice. All data without warranty, price as of 13.11.2026. Details in the risk notice.